Frontiers in adjuvant therapy in stage II-III melanoma.
Eggermont
A M
AM
Department of Surgical Oncology. University Hospital Rotterdam, Daniel Den Hoed Cancer Center Rotterdam, The Netherlands. eggermont@chih.azr.nl
D000276:Adjuvants, Immunologic / Q000008:administration & dosage / Q000627:therapeutic use*; D019496:Cancer Vaccines / Q000008:administration & dosage / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D006801:Humans; D016898:Interferon-alpha / Q000008:administration & dosage / Q000627:therapeutic use*; D008545:Melanoma / Q000628:therapy*
D000276:Adjuvants, Immunologic; D019496:Cancer Vaccines; D016898:Interferon-alpha